NF-κB mediates amyloid β peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells

作者: Yansheng Du , Xianming Chen , Xing Wei , Kelly R. Bales , David T. Berg

DOI: 10.1016/J.MOLBRAINRES.2005.02.001

关键词:

摘要: Abstract The apolipoprotein E gene (APOE) plays an important role in the pathogenesis of Alzheimer's disease (AD), and amyloid plaque comprised mostly amyloid-beta peptide (Aβ) is one major hallmarks AD. However, relationship between these two molecules poorly understood. We examined how Aβ treatment affects APOE expression cultured cells tested transcription factor NF-κB regulation. To delineate NF-κB's role, we have characterized a 1098 nucleotide (nt) segment containing 5′-flanking region human (−1054/+44, +1 start site). Sequence analysis this suggests presence potential elements. demonstrate promoter activity, was cloned upstream promoterless luciferase (reporter) gene. This able to drive transient transfections fetal glial cells. Promoter activity stimulated twofold by Aβ1–40 (25 μM, 24 h) treatment. Pretreatment with double-stranded DNA decoy oligonucleotides against (2 μM) reduced stimulation. Deletion mutagenetic analyses demonstrated that distal element functional showed strong DNA–protein complex band gel shift analysis, similar from control consensus element. An anti-inflammatory anti-NF-κB drug, sodium salicylate, significantly blocked Aβ-induced function. Our data provide evidence upregulation astroglial mediated NF-κB-element present

参考文章(54)
E.B. Traenckner, H.L. Pahl, T. Henkel, K.N. Schmidt, S. Wilk, P.A. Baeuerle, Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. The EMBO Journal. ,vol. 14, pp. 2876- 2883 ,(1995) , 10.1002/J.1460-2075.1995.TB07287.X
Josep Saura, Valerie Petegnief, Xin Wu, Yanbin Liang, Steven M. Paul, Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide Journal of Neurochemistry. ,vol. 85, pp. 1455- 1467 ,(2003) , 10.1046/J.1471-4159.2003.01788.X
A. Golabek, T. Wisniewski, E. M. Castaño, B. Frangione, T. Vogel, ACCELERATION OF ALZHEIMER'S FIBRIL FORMATION BY APOLIPOPROTEIN E IN VITRO American Journal of Pathology. ,vol. 145, pp. 1030- 1035 ,(1994)
D J Chang, Y K Paik, T P Leren, D W Walker, G J Howlett, J M Taylor, Characterization of a human apolipoprotein E gene enhancer element and its associated protein factors. Journal of Biological Chemistry. ,vol. 265, pp. 9496- 9504 ,(1990) , 10.1016/S0021-9258(19)38877-5
Min-Jean Yin, Yumi Yamamoto, Richard B. Gaynor, The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β Nature. ,vol. 396, pp. 77- 80 ,(1998) , 10.1038/23948
Yuling Sun, Shan Wu, Guojun Bu, Moyosore K. Onifade, Shilen N. Patel, Mary Jo LaDu, Anne M. Fagan, David M. Holtzman, Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins The Journal of Neuroscience. ,vol. 18, pp. 3261- 3272 ,(1998) , 10.1523/JNEUROSCI.18-09-03261.1998
J A Brockman, D C Scherer, T A McKinsey, S M Hall, X Qi, W Y Lee, D W Ballard, Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Molecular and Cellular Biology. ,vol. 15, pp. 2809- 2818 ,(1995) , 10.1128/MCB.15.5.2809
B.A In ’t Veld, L.J Launer, A.W Hoes, A Ott, A Hofman, M.M.B Breteler, B.H.Ch Stricker, NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiology of Aging. ,vol. 19, pp. 607- 611 ,(1998) , 10.1016/S0197-4580(98)00096-7